Showing results (1341-1350 of 1,648) with videos related to

Sort By:
Pageof 165
Annals of Surgical Oncology|October 14, 2020
An Aggressive Approach to Locally Confined Pancreatic Cancer: Defining Surgical and Oncologic Outcomes Unique to Pancreatectomy with Celiac Axis Resection (DP-CAR)Ryan K Schmocker, Michael J Wright, Ding Ding, et al.
Cancer Treatment Reviews|June 1, 2025
Adjuvant therapy after resection of intraductal papillary mucinous neoplasm-derived pancreatic cancer: A systematic review and meta-analysisJoseph R Habib, Asad Saulat Fatimi, Omar Mahmud, et al.
Nanoscale|May 23, 2025
Spin-multiplexed phase and amplitude manipulations of terahertz waves based on chiral metasurfacesLi Luo, Jialuo Ding, Yuxin Zou, et al.
Journal of Immunology Research|November 12, 2020
Genetic Mutations of Tim-3 Ligand and Exhausted Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells and Survival in Diffuse Large B Cell LymphomaTingting Zhang, Tianyuan Ren, Zheng Song, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 27, 2019
Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancerVincent P Groot, Alex B Blair, Georgios Gemenetzis, et al.
British Journal of Haematology|October 19, 2021
Tracking the evolution of untreated high-intermediate/high-risk diffuse large B-cell lymphoma by circulating tumour DNASicong Zhang, Tingting Zhang, Hengqi Liu, et al.
Frontiers in Neurology|April 19, 2021
Cerebral Metabolism Related to Cognitive Impairments in Multiple System AtrophyCong Shen, Li Chen, Jing-Jie Ge, et al.
AJR. American Journal of Roentgenology|September 1, 2021
CT Radiomics-Based Preoperative Survival Prediction in Patients With Pancreatic Ductal AdenocarcinomaSeyoun Park, Jonathan G Sham, Satomi Kawamoto, et al.
JCO Precision Oncology|February 12, 2025
Cancer Susceptibility Gene Testing in Patients With Pancreatic Ductal Adenocarcinoma: Implementation in a Cancer Center Oncology ClinicHassan Sinan, Dea Cunningham, Emy Abou Sleiman, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|June 6, 2023
Phase I, Randomized, Placebo-Controlled, Dose-Escalation Study of GB223, a Fully-Humanized Monoclonal Antibody to RANKL, in Healthy Chinese AdultsChen Li, Haiyan Liu, Yixiang Liao, et al.
Pageof 165